Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)
Clinical trial NCT02522767 · COMPLETED
Trial details
- NCT number
- NCT02522767
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2018-02-06
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.